Clozapine

Global Calcium is one of the leading manufacturers and exporters of Clozapine CAS no. 5786-21-0, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Clozapine we hereby state the following facts about the drug:

Clozapine is an FDA-approved atypical antipsychotic drug for treatment-resistant schizophrenia. The definition of treatment-resistant schizophrenia is persistent or moderate delusions or hallucinations after failing two trials of antipsychotic medicines. Since its creation, it has been the drug of choice for treatment-resistant schizophrenia.  meta-analysis done in 2018 showed that clozapine might be more effective than other antipsychotics even when used as a first- or second line of treatment.

Other advantages include that clozapine lowers risk of suicide, Lower risk for tardive dyskinesia, Improvement of cognition which can lead to improved quality of life, Decreased relapse

Regarding suicide risk, clozapine has been shown to reduce suicidal behaviour even in patients with non-treatment-resistant schizophrenia and schizoaffective disorder.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market